Apotheca Biosciences (PCFP) Stock Price, News & Analysis

Company Overview

Apotheca Biosciences, Inc. (OTCMKTS:PCFP) is a biotechnology company focused on the development and commercialization of rapid immunoassay products for clinical diagnostics, biodefense and environmental monitoring. The company leverages proprietary monoclonal antibody reagents and detection platforms to deliver high‐sensitivity, point‐of‐care tests capable of identifying toxins, pathogens and biomarkers across a variety of sample matrices.

Key offerings include lateral flow immunoassays and enzyme‐linked immunosorbent assays (ELISAs) designed for on‐site detection of biological threat agents, food and water contaminants, and clinically relevant analytes. Apotheca’s assays are tailored to government agencies, healthcare providers and industrial quality‐control laboratories, with formats suited for both disposable test strips and benchtop instrumentation.

Beyond its standard product lines, Apotheca Biosciences provides contract research and custom assay development services, supporting third‐party clients that require specialized immunodiagnostic solutions. The company collaborates with academic institutions, government research centers and private‐sector partners to advance its technology pipeline, serving primarily the U.S. market while maintaining select international distribution agreements.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 264,300 shs
• Average Volume: 45,056 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Food Products
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PCFP
• CIK: 1632053
• Web: www.cannabisleafinc.co
• Phone: (727) 228-3994
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A